Does your itchy dog need to see the veterinarian?


Apoquel is a revolutionary prescription medicine that stops allergic dog itch—right at the source

APOQUEL (oclacitinib tablet) is a revolutionary dog allergy medicine that works differently than other treatments. APOQUEL goes right to the source to stop the underlying cause of allergic itch in dogs 12 months and older. So you and your dog can get back to the life you love—without all that scratching, licking, and chewing!

APOQUEL (oclacitinib tablet) relieves dog itch fast


APOQUEL starts relieving allergic dog itch in 4 hours—and controls it within 24 hours.1,2

APOQUEL (oclacitinib tablet) works right at the source of allergic dog itch


APOQUEL works right at the source to stop itching and relieve inflammation in dogs. APOQUEL is a prescription dog allergy medicine used for the control of itch associated with allergic dermatitis and control of atopic dermatitis in dogs 12 months and older. APOQUEL reduces dog itch, and also decreases inflammation, redness, or swelling of the skin—so your dog feels better as quickly as possible.

APOQUEL (oclacitinib tablet) is safe for the long-term treatment of allergic dog itch


APOQUEL is safe to use in dogs 12 months of age or older.

Additionally, APOQUEL:

  • Can be used long-term for maintenance therapy3
  • Is not for use in dogs with serious infections, or for use in breeding, pregnant or, lactating dogs


In a short-term clinical study, the most common side effects were vomiting and diarrhea. These occurred in only a small percentage of dogs treated with APOQUEL. These side effects typically stopped on their own.2,4


With APOQUEL, your dog is less likely to suffer from the kinds of side effects often seen with steroids. These include behavior changes (stress, anxiety, aggression), excessive drinking and urinating, panting, and weight gain.2,4,5

Steroids can have potential side effects

Understandably, weighing the side effects and the need for itch relief can feel like you are on an emotional roller coaster. But, knowing the facts will help you and your dog's veterinarian make the best choice for relief.


These include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, carprofen)
  • Vaccines (eg, rabies)
  • Allergy shots and drops (eg, allergen-specific immunotherapy)

The use of APOQUEL has not been evaluated in combination with other systemic immunosupressants, such as corticosteroids and cyclosporine.

APOQUEL is available only by prescription from your veterinarian. So ask about APOQUEL today.
APOQUEL dosing

Improvement in quality of life worth
barking about

Dog owners feel APOQUEL improved quality of life for their dogs—and for themselves!6

APOQUEL (oclacitinib tablet) showed 97% improvement in quality of dog’s life
APOQUEL (oclacitinib tablet) showed 95% improvement in quality of owner’s life

APOQUEL has helped so many dogs get relief of allergic dog itch

See how APOQUEL helped provide relief of allergic dog itch


Control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.


Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.


References: 1. Gadeyne C, Little P, King VL, Edwards N, Davis K, Stegemann MR. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol. 2014;25(6):512-518, e86. doi: 10.1111/vde.12166. 2. Cosgrove SB, Wren JA, Cleaver DM, et al. Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol. 2013;24(5):479-e114. doi: 10.1111/vde.12047. 3. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171–179, e35. 4. Cosgrove SB, Wren JA, Cleaver DM, et al. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis. Vet Dermatol. 2013;24(6):587-597, e141-142. doi: 10.1111/vde.12088. 5. Sousa CA. Glucocorticoids in veterinary dermatology. In: Bonagura JD, Twedt DC, eds. Kirk’s Current Veterinary Therapy. 14th ed. St. Louis, MO: Saunders Elsevier; 2009:400-404. 6. Data on file. Pet Owner Survey Aggregate Report 4-10-14.